iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
In India’s IPO market, grey market premium (GMP) is an informal pre-listing quote for IPO shares or related rights. Adding it to the issue price gives the quote’s implied price; it does not predict or guarantee the exchange listing price. Treat GMP as a changeable snapshot of informal sentiment, not an official price or a measure of a company’s quality.
What does GMP mean in an IPO?
Grey market premium is the amount by which an informal pre-listing quote is above or below an IPO’s issue price. It comes from trading or dealer-reported quotes outside recognized exchange processes. SEBI, stock exchanges and registrars do not publish an official GMP figure, according to Chittorgarh.
Because the activity is informal, GMP can differ from one reporting source to another and can change quickly. It is not the same thing as an exchange-traded market price. The available information does not establish that every transaction in the grey market is legal or illegal; legality should not be inferred without authority specific to the transaction.
How do you calculate GMP and its implied price?
Use the issue price and the quoted GMP. If the quote is based on a point in the IPO price band rather than the final issue price, identify that reference clearly.
#1 Best Overall
- Implied price: issue price + quoted GMP.
- GMP percentage: quoted GMP ÷ issue price × 100.
For example, with an issue price of ₹200 and a quoted GMP of ₹50, the arithmetic gives an implied price of ₹250 and a GMP of 25% (₹50 ÷ ₹200 × 100). That ₹250 is only the quote’s implied price—not an official, expected or assured listing price.
Always give a real quote’s source and timestamp: the figure can move, and publishers may report different values. A missing quote is not automatically a GMP of ₹0; one publisher explicitly distinguishes a missing report from a zero figure (Chittorgarh’s GMP page).
What can GMP tell you?
At most, a rising or falling quote can offer a rough snapshot of short-term interest in an IPO within the informal market. It may move alongside subscription levels, broader market conditions or sentiment, but the available sources do not establish that any one of those factors causes a particular GMP or listing outcome.
Recommended Free Tools
It can be one limited input when considering how market participants appear to be reacting before listing. Its usefulness depends on knowing who reported it, when it was reported, what price it references and whether the IPO is main-board or SME. An unattributed or stale number offers little basis for comparison.
What can GMP not tell you?
- The eventual listing price: GMP does not establish the opening, intraday high, closing price or later trading price. These are distinct outcomes.
- Whether a company is good value: a premium does not assess earnings quality, cash flows, debt, governance, business risks or valuation.
- Whether the IPO suits you: an informal quote cannot account for your objectives, risk tolerance or investment horizon.
- Long-term performance: a pre-listing sentiment signal does not establish returns after the listing day.
SEBI’s archived disclosure guidance makes a related, narrower point about the issue price—not GMP itself: “The issue price/ floor price/ price band (has been determined and justified by the Lead Merchant Banker and the issuer company as stated under Justification of Premium paragraph – in case of premium issue) should not be taken to be indicative of the market price of the equity shares after they are listed.” The archived page is useful context, but it is not a current consolidated rulebook: SEBI’s archived disclosure guidance.
Does research show that GMP predicts listing performance?
One 2024 study by Sohom Ghosh, Arnab Maji, N Harsha Vardhan and Sudip Kumar Naskar compared GMP-based estimates with listing-day outcomes, analyzing main-board and SME IPOs separately. For its full main-board sample, it reported a mean absolute error (MAE) of 0.109 and mean squared error (MSE) of 0.031 for its GMP-based opening-price underpricing estimate. For its full SME sample, the corresponding figures were 0.751 and 1.509.
For the study’s 2023-only samples, the main-board MAE and MSE were 0.091 and 0.019; the SME figures were 0.531 and 0.771. These are the paper’s error metrics, not percentages or accuracy rates, and they are specific to its data and method. The authors concluded that GMP could serve as a proxy for estimating main-board IPO success in their dataset, but was not a good indicator for SME IPOs. The results do not establish how accurately GMP will predict any individual IPO’s listing. See the 2024 study.
Free tools Windows power users keep installed
One-click scans. No signup required.
How should you use GMP when assessing an IPO?
- Check the quote’s source and time. Record who reported it and when. Do not treat figures from different sources or timestamps as directly comparable without noting the difference.
- Confirm the price reference. Check whether the GMP is being compared with the final issue price or a point in the price band, then calculate the implied price and percentage accordingly.
- Keep the IPO segment in view. Do not transfer findings about main-board IPOs to SME IPOs; the cited study reported substantially different errors for its two samples.
- Read the offer document. Assess the issuer’s financials, risks, cash flows, debt, valuation, promoter selling and planned use of proceeds rather than using GMP as a substitute.
- Compare with official IPO information. Use formal disclosures and subscription information as context, while keeping them distinct from informal quotes.
- Define the outcome you care about. An opening price, listing-day high, closing price and longer-term return are not interchangeable measures of success.
“GMP is 40%. Should I apply?”
A 40% GMP, if current and accurately reported, describes an informal premium relative to the issue price; it does not answer whether you should apply. First verify the source, timestamp and price reference. Then assess the offer document, the company’s risks and valuation, and the official IPO information in light of your own investment objectives. Do not treat the percentage as a promised listing gain.
“The market appears excited. Does the RHP justify that excitement?”
That requires reading the Red Herring Prospectus (RHP), not relying on GMP. Examine the business and financials, key risks, valuation, promoter selling and use of proceeds. A high informal premium can coexist with risks or a valuation you consider unattractive; the quote alone cannot establish that the offer is justified.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
